Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. [electronic resource]
Producer: 20090416Description: 2166-73 p. digitalISSN:- 1078-0432
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm -- administration & dosage
- Cancer Vaccines -- administration & dosage
- Cholesterol -- administration & dosage
- Drug Combinations
- Female
- Humans
- Hypersensitivity, Delayed -- etiology
- Male
- Melanoma -- therapy
- Membrane Proteins -- administration & dosage
- Middle Aged
- Phospholipids -- administration & dosage
- Saponins -- administration & dosage
- T-Lymphocytes -- immunology
- T-Lymphocytes, Regulatory -- physiology
- Vaccination
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.